Companies must also take a very precise look at their markets and know who will buy and use their products. Companies seeking rapid increases in equity value over a very short term are not best placed to be patient in this way. Two of the most interesting ongoing stories of the recent past few years are Abbott's ongoing success and the rise and rise of Thermo Trilogy. Both are well-positioned to succeed. New companies have been formed with fairly focussed objectives and older companies have had to become more focussed also.
Realism appears to be in fashion.
Bioportfolio Ltd are pleased to announce the availability of this publication to our readers. It is available either as four separate volumes on Markets , Technology , Legislation and Companies , or as a complete study. Please click the volumes to review extracts and the Executive Summary . All purchasers receive the Executive Summary plus a four-volume index and table of contents. All rights reserved.